 |
|
|
| Press Releases |
| LabVantage in the News 2002 |
|
|
|
| LabVantage Continues to Expand Leadership Position for Growing CRO Market |
|
New Orleans, Louisiana March 4, 2001. Key Customer Wins Further Validate Browser-Based Virtual Laboratory Position
LabVantage Solutions, Inc., a leading provider of laboratory information solutions, announced today at Pittcon, that it continues to expand its leadership position for the growing Contract Research Organization (CRO) market.
According to the latest survey conducted by the Pharmaceutical Outsourcing Management Association, outsourcing spending by pharmaceutical companies increased significantly in 2000 from 1999. Ninety percent of the survey's participants reported increased outsourcing spending in 2000 and expect spending on CROs to continue to grow in 2001. As the CRO market has grown, they have begun to see a much more focused approach to solution offerings. The major success factor for solution providers is based on providing more market-specific, high-performance technology with an expandable capacity and quicker delivery speed. The survey also indicated that CROs need tools to help them integrate their data to speed their processes and to connect with their customers outside of the laboratory.
Customer Service Takes Center Stage. Two of the most important strengths a CRO laboratory must have today are the ability to provide superior customer service and to rapidly reconfigure solutions to meet the needs of a variety of customers. These capabilities are forcing many of today's traditional labs to come under management scrutiny and adding pressure to improve their service levels. Providing superior customer service is the cornerstone of today's virtual laboratory.
"Contract research organizations are a vital resource in an industry that continues to look for ways to improve customer service capabilities, while reducing operating costs," said Scott Deutsch, vice president, global marketing for LabVantage. "Traditional labs need to look at their ability to deliver information to their virtual customers via their LAN, WAN or the Internet without all of the costs and overhead associated with older client/server environments."
LabVantage Recent Successes Pertaining to This Trend
LabVantage is helping a number of CROs build their virtual laboratory, including:
| |
 |
Pharma Bio-Research Group B.V. (Zuidlaren, The Netherlands) - conducts clinical and bio-analytical research for pharmaceutical and biotechnology companies worldwide. |
| |
|
University of Guelph (Guelph, Ontario, Canada) - Canada's largest provider of analytical research, regulatory testing, consultative services and comprehensive laboratory diagnostic services in support of agriculture and food excellence. |
| |
|
CEDRA (Austin, Texas) - a provider of excellence in biotechnical services for the pharmaceutical industry and the federal government. |
| |
|
Caleb Brett USA (Houston, Texas) - a division of Intertek Testing Services, a world leader in providing independent assessment of crude oil, petroleum and chemical products and agricultural products. |
LabVantage Sapphire™ enables the CRO market to meet its aggressive business and technology requirements by equipping laboratories with a scalable, easy-to-configure automation solution. The solution's ability to seamlessly connect various customers gives CRO laboratories a competitive advantage and therefore helps them to provide superior customer service.
Architecture and Usability Key Elements. Sapphire™ 3.0 is a 100-percent browser-based solution that does not require Citrix servers or any plug-ins or applets to be downloaded to provide browser-based functionality. Sapphire™ is a browser/server solution that has a complete three-tiered architecture and a scalable application server layer.
Sapphire™ 3.0 was designed with two key design criteria: first, access to functionality must be self-evident, and second, the user must be able to execute a desired task with a single click. No more than two clicks would be acceptable. LabVantage's mission was to stop the "menu-tree madness" that exists with mature client/server applications. For today's leading CROs, it is critical that training and education costs be kept to a minimum.
LabVantage Sapphire™ -- The Leading Solution for World-Class CROs. LabVantage Sapphire™ is a leading laboratory software solution that helps leading laboratories build the virtual laboratory and increase productivity, lower operating costs, and improve quality and customer service. Sapphire™'s configurable process automation and communication capabilities allow laboratories of any size to model their business-specific workflows, seamlessly integrate with robots and analytical instruments, leverage the Internet for internal and external communications, and meet the growing demands of high throughput environments. Sapphire™ was developed in collaboration with leading laboratories around the world to provide the functionality, flexibility and scalability that will meet customers' needs both today and in the future.
About LabVantage Solutions. LabVantage Solutions, a Chatterjee Group company, develops, markets and supports a complete suite of software for high throughput screening, genomics, proteomics and LIMS. In addition, LabVantage offers ASP services and provides industry-specific global solutions for select markets including pharmaceutical research and development, pharmaceutical contract research organizations, food and beverage, oil and gas, process chemicals, forensics and environmental. The company offers the services that ensure customer success such as industry and technology consulting, implementation services, application training and extensive customer support services. LabVantage has provided laboratory information solutions to nearly 1,000 companies since 1981. For further information about LabVantage Solutions, please visit our web site at www.labvantage.com.
Certain statements contained in this release may be forward-looking statements and are thus prospective. Such forward-looking statements are subject to risks, uncertainties and other factors which could cause actual results to differ materially from future results expressed or implied by such forward-looking statements.
|
|
|
|
|
|
